Topical bromfenac for pain reduction after intravitreal injection

Phase 3 trial of bromfenac sodium in Ocular pain is not a disease; it is a symptom. The canonical disease entity most closely related to persistent, unexplained ocular pain is "ocular neuropathic pain" or "neuropathic ocular pain" (2 arms), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Primary endpoint: Perceived pain on the third day after injection. Started May 2016; status: completed.